Przejdź do zawartości
Merck

Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay.

Journal of biomolecular screening (2007-01-30)
Zhengrong Zhu, Jaime Puglisi, David Connors, Jeremy Stewart, John Herbst, Anthony Marino, Michael Sinz, Jonathan O'Connell, Martyn Banks, Kenneth Dickinson, Angela Cacace
ABSTRAKT

Cryopreserved, transiently transfected HepG2 cells were compared to freshly transfected HepG2 cells for use in a pregnane X receptor (PXR) transactivation assay. Assay performance was similar for both cell preparations; however, cryopreserved cells demonstrated less interassay variation. Validation with drugs of different PXR activation potencies and efficacies demonstrated an excellent correlation (r(2) > 0.95) between cryopreserved and fresh cells. Cryopreservation did not change the effect of known CYP3A4 inducers that have poor cell permeability, indicating that cryopreservation had little effect on membrane permeability. In addition, cryopreserved HepG2 cells did not exhibit enhanced susceptibility to cytotoxic compounds compared to transiently transfected control cells. The use of cryopreserved cells enables this assay to run with enhanced efficiency.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sulfinpyrazone, European Pharmacopoeia (EP) Reference Standard
Supelco
(±)-Sulfinpyrazone, analytical standard